Smith & Nephew plc 14% Potential Upside Indicated by Morgan Stanley

Broker Ratings

Smith & Nephew plc using EPIC/TICKER code (LON:SN) had its stock rating noted as ‘Upgrades’ with the recommendation being set at ‘OVERWEIGHT’ today by analysts at Morgan Stanley. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. Morgan Stanley have set a target price of 1950 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 14.0% from today’s opening price of 1710 GBX. Over the last 30 and 90 trading days the company share price has increased 120.5 points and decreased 19 points respectively. The 1 year high for the stock price is 2023 GBX while the 52 week low for the share price is 1055.01 GBX.

Smith & Nephew plc has a 50 day moving average of 1,580.97 GBX and the 200 Day Moving Average price is recorded at 1,746.06. There are currently 875,549,543 shares in issue with the average daily volume traded being 2,297,517. Market capitalisation for LON:SN is £14,781,983,232 GBP.

Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:


      AIM All Share Index